PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia
· Delayed Price · Currency is IDR 121.00
+2.00 (1.68%)
Apr 25, 2025, 3:25 PM WIB
IDX:SDPC Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 3,916,864 | 3,363,518 | 3,200,833 | 2,988,849 | 2,643,627 | Upgrade
|
| Revenue Growth (YoY) | 16.45% | 5.08% | 7.09% | 13.06% | -3.05% | Upgrade
|
| Cost of Revenue | 3,582,487 | 3,073,699 | 2,933,936 | 2,751,812 | 2,426,333 | Upgrade
|
| Gross Profit | 334,377 | 289,819 | 266,897 | 237,036 | 217,293 | Upgrade
|
| Selling, General & Admin | 226,191 | 193,007 | 186,311 | 176,214 | 159,860 | Upgrade
|
| Other Operating Expenses | 11,752 | 4,096 | 6,687 | 3,348 | 4,662 | Upgrade
|
| Operating Expenses | 237,943 | 197,102 | 192,998 | 179,562 | 164,522 | Upgrade
|
| Operating Income | 96,434 | 92,717 | 73,900 | 57,475 | 52,771 | Upgrade
|
| Interest Expense | -68,791 | -57,577 | -38,482 | -39,894 | -45,117 | Upgrade
|
| Interest & Investment Income | - | 139.72 | 984.05 | 80.14 | 84.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 59.01 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 27,701 | 35,280 | 36,402 | 17,660 | 7,739 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 12,681 | 62.49 | 262.22 | 0.85 | Upgrade
|
| Pretax Income | 27,701 | 47,961 | 36,464 | 17,923 | 7,739 | Upgrade
|
| Income Tax Expense | 10,787 | 14,880 | 12,000 | 8,351 | 4,935 | Upgrade
|
| Earnings From Continuing Operations | 16,914 | 33,081 | 24,464 | 9,571 | 2,804 | Upgrade
|
| Minority Interest in Earnings | 14.75 | 6.33 | - | - | - | Upgrade
|
| Net Income | 16,929 | 33,088 | 24,464 | 9,571 | 2,804 | Upgrade
|
| Net Income to Common | 16,929 | 33,088 | 24,464 | 9,571 | 2,804 | Upgrade
|
| Net Income Growth | -48.84% | 35.25% | 155.60% | 241.30% | -64.41% | Upgrade
|
| Shares Outstanding (Basic) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | Upgrade
|
| Shares Outstanding (Diluted) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | - | - | - | Upgrade
|
| EPS (Basic) | 13.29 | 25.97 | 19.20 | 7.51 | 2.20 | Upgrade
|
| EPS (Diluted) | 13.29 | 25.97 | 19.20 | 7.51 | 2.20 | Upgrade
|
| EPS Growth | -48.83% | 35.25% | 155.60% | 241.30% | -64.41% | Upgrade
|
| Free Cash Flow | -139,609 | -111,587 | -115,306 | -22,649 | 67,880 | Upgrade
|
| Free Cash Flow Per Share | -109.60 | -87.59 | -90.51 | -17.78 | 53.28 | Upgrade
|
| Dividend Per Share | - | 2.500 | 2.000 | 1.000 | 0.500 | Upgrade
|
| Dividend Growth | - | 25.00% | 100.00% | 100.00% | -50.00% | Upgrade
|
| Gross Margin | 8.54% | 8.62% | 8.34% | 7.93% | 8.22% | Upgrade
|
| Operating Margin | 2.46% | 2.76% | 2.31% | 1.92% | 2.00% | Upgrade
|
| Profit Margin | 0.43% | 0.98% | 0.76% | 0.32% | 0.11% | Upgrade
|
| Free Cash Flow Margin | -3.56% | -3.32% | -3.60% | -0.76% | 2.57% | Upgrade
|
| EBITDA | 106,682 | 92,723 | 79,868 | 63,699 | 59,617 | Upgrade
|
| EBITDA Margin | 2.72% | 2.76% | 2.50% | 2.13% | 2.25% | Upgrade
|
| D&A For EBITDA | 10,248 | 6.43 | 5,968 | 6,225 | 6,846 | Upgrade
|
| EBIT | 96,434 | 92,717 | 73,900 | 57,475 | 52,771 | Upgrade
|
| EBIT Margin | 2.46% | 2.76% | 2.31% | 1.92% | 2.00% | Upgrade
|
| Effective Tax Rate | 38.94% | 31.02% | 32.91% | 46.60% | 63.77% | Upgrade
|
| Advertising Expenses | - | 2,035 | 1,642 | 8,126 | 8,974 | Upgrade
|
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.